Inogen | INGN - Umlaufvermögen





Umlaufvermögen Veränderung Datum
Abbott USD 25.51B 488M 2026-03
Accuray USD 292.39M 11.22M 2025-12
AngioDynamics USD 161.35M 4.69M 2025-09
Artivion USD 371.38M 13.86M 2026-06
AtriCure USD 345.53M 31.84M 2026-06
Baxter International USD 6.99B 142M 2026-06
Becton, Dickinson and Co. USD 8.14B 127M 2026-06
Boston Scientific USD 7.97B 712M 2026-06
Cooper Companies USD 2.3B 166M 2026-03
Dexcom USD 4.09B 245.1M 2026-06
Edwards Lifesciences USD 6.82B 590.2M 2026-06
Globus Medical USD 2.22B 17.39M 2026-06
Inogen USD 203.72M 594K 2025-09
Insulet USD 1.85B 139.6M 2026-06
Medtronic USD 24.07B 75M 2025-12
Orthofix International USD 446.13M 15.39M 2026-06
Philips EUR 9.33B 454M 2026-06
ResMed USD 4.32B 260.68M 2026-06
Steris USD 2.45B 51.2M 2026-06
Stryker USD 14.42B 1.08B 2026-06
Tandem Diabetes Care USD 804.64M 82.46M 2026-06
Teleflex USD 1.88B 16.21M 2026-06
X T L Biopharmaceuticals USD 166K 367K 2025-12
Zimmer Biomet Holdings USD 5.1B 134.2M 2026-06